(MedPage Today) — Real-world effectiveness with the recommended single dose of respiratory syncytial virus (RSV) vaccination dipped in older adults over the first 18 months, a finding that could support boosters for high-risk groups such as the…
Source link : https://www.medpagetoday.com/infectiousdisease/rsv/118718
Author :
Publish date : 2025-11-25 21:15:00
Copyright for syndicated content belongs to the linked Source.
